Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Tax Provisions (2018 - 2025)

Historic Tax Provisions for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $1.5 million.

  • Viemed Healthcare's Tax Provisions fell 370.14% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 3683.86%. This contributed to the annual value of $4.8 million for FY2024, which is 1477.82% up from last year.
  • Viemed Healthcare's Tax Provisions amounted to $1.5 million in Q3 2025, which was down 370.14% from $1.7 million recorded in Q2 2025.
  • Viemed Healthcare's 5-year Tax Provisions high stood at $1.9 million for Q4 2024, and its period low was -$223000.0 during Q1 2021.
  • Over the past 5 years, Viemed Healthcare's median Tax Provisions value was $1.0 million (recorded in 2025), while the average stood at $1.0 million.
  • The largest annual percentage gain for Viemed Healthcare's Tax Provisions in the last 5 years was 54105.96% (2021), contrasted with its biggest fall of 21925.13% (2021).
  • Quarter analysis of 5 years shows Viemed Healthcare's Tax Provisions stood at $968000.0 in 2021, then grew by 18.39% to $1.1 million in 2022, then soared by 39.53% to $1.6 million in 2023, then increased by 17.64% to $1.9 million in 2024, then dropped by 18.39% to $1.5 million in 2025.
  • Its Tax Provisions stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.0 million for Q1 2025.